SkimSkim home
AwardedPOLGoods

Sukcesywna dostawa produktów leczniczych (ruksolitynib) do realizacji niekomercyjnego badania klinicznego „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway”

Published
Published 3 April 2025
Deadline
Closed 9 May 2025
Book a demoHow Skim finds tendersView original notice ↗

Overview

Sukcesywna dostawa produktów leczniczych (ruksolitynib) do realizacji niekomercyjnego badania klinicznego „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway” Badanie kliniczne „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway” w ramach projektu "Childhood ALL in Poland (CALL-POL) project: a national harmonization of diagnostics and treatment of acute lymphoblastic leukemia in children”

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
3 April 2025
Deadline
Closed
Classification (CPV)
Pharmaceutical productsVarious medicinal productsMedical solutions

Award outcome

Awarded value
PLN 440,426
Award date
18 June 2025
Contract period
— → 8 June 2027
Winner
  • Urtica Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    1 July 2025

  2. Contract Notice

    2 May 2025

  3. Contract Notice

    3 April 2025

Contracting authority

  • Uniwersytet Medyczny w Łodzi

    Procuring entity

    Łódź, POL

Book a demo to unlock contact details

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

Book a call

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Book a call
Awarded: Sukcesywna dostawa produktów leczniczych (ruksolitynib) do realizacji niekomercyjnego badania klinicznego „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway” — won by Urtica Sp. z o.o. — Skim